Sector ratings Laboratorios Farmaceuticos Rovi, S.A. Wiener Boerse
Stocks
ROVI
ES0157261019
Pharmaceuticals
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.85 EUR | -0.68% |
|
+0.94% | -6.40% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 1,030B | A | |||||||
| 617B | BBB | |||||||
| 455B | AA | - | ||||||
| 350B | AA | |||||||
| 299B | AAA | |||||||
| 265B | A | |||||||
| 225B | A | |||||||
| 209B | A | |||||||
| 163B | AA | |||||||
| 142B | A | |||||||
| 132B | A | |||||||
| 122B | AA | |||||||
| 101B | AA | |||||||
| 104B | AA | |||||||
| 72.96B | AA | |||||||
| 57.26B | AA | |||||||
| 54.79B | AA | |||||||
| 53.29B | AA | |||||||
| 43.65B | AA | |||||||
| Average | 236.63B | AA | |||||||
| Weighted average by Cap. | AA |
Select your edition
All financial news and data tailored to specific country editions
